Skip to main content
An official website of the United States government

Gastrointestinal and Other Cancers

Conducts and supports prevention and early detection research for colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers. Supports development of new approaches for clinical prevention studies, including cancer immunoprevention.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Della'Zanna, Gary, D.O., M.Sc.
gary.dellazanna@nih.gov
240-276-7042
5E234 Program Officer | Gastrointestinal and Other Cancers
Garvey, Rodshae
garveyrj@nih.gov
240-276-5764
5E220 Program Support Assistant | Gastrointestinal and Other Cancers
Program Support Assistant | Lung and Upper Aerodigestive Cancer
Rodriguez, Luz Maria, M.D., FACS
luz.rodriguez@nih.gov
240-276-7039
5E228 Program Officer | Gastrointestinal and Other Cancers
Umar, Asad, D.V.M., Ph.D.
asad_umar@nih.gov
240-276-7038
5E226 Chief | Gastrointestinal and Other Cancers

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Lipkin, Steven M

Weill Medical Coll Of Cornell Univ
United States

CAP-IT Center for LNP RNA Immunoprevention 5U54CA272688-04 John Clifford, Ph.D.
Liu, Yang

University Of Illinois At Urbana-Champaign
United States

Imaging nanoscale chromatin folding in early carcinogenesis 5R01CA254112-07 Matthew Young, Ph.D.
Liu, Changchun

University Of Connecticut Sch Of Med/Dnt
United States

Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care 3U01CA269147-04S1 Christos Patriotis, Ph.D., M.Sc.
Livneh, Zvi

Weizmann Institute Of Science
United States

Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort 5U01CA279001-03 Claire Zhu, Ph.D.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer 5R01CA254036-05 Matthew Young, Ph.D.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms 5R01CA247220-05 Christos Patriotis, Ph.D., M.Sc.
Lowry, Kathryn Paige

University Of Washington
United States

Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations 5R37CA292399-02 Claire Zhu, Ph.D.
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 4R01CA260901-04 Gabriela Riscuta, M.D., CNS
Lubman, David M.

University Of Michigan At Ann Arbor
United States

Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach 5R01CA160254-14 Matthew Young, Ph.D.
Lyden, David Charles

Weill Medical Coll Of Cornell Univ
United States

Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection 5R01CA218513-08 Matthew Young, Ph.D.
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-04 Young Kim, Ph.D.
Madeleine, Margaret M

Fred Hutchinson Cancer Center
United States

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center 3U54CA242977-07S4 Maria Silvina Frech, Ph.D., M.S.
Mahan, Kristin Eckel

University Of Texas Hlth Sci Ctr Houston
United States

Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain 1R21CA292148-01 John Clifford, Ph.D.
Maitra, Anirban

New York University School Of Medicine
United States

Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-09 Matthew Young, Ph.D.